|
|
Volumn 77, Issue 9, 1996, Pages 1959-1960
|
|
Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma [3]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
TAMOXIFEN;
VINBLASTINE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CASE REPORT;
DOSE RESPONSE;
DRUG EFFICACY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
LETTER;
PLEURA MESOTHELIOMA;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
HUMANS;
MESOTHELIOMA;
PLEURAL NEOPLASMS;
PROSPECTIVE STUDIES;
REMISSION INDUCTION;
|
|
EID: 0029867893
PISSN: 0008543X
EISSN: None
Source Type: Journal
DOI: 10.1002/(SICI)1097-0142(19960501)77:9<1959::AID-CNCR32>3.0.CO;2-X Document Type: Letter |
|
Times cited : (4)
|
|
References (0)
|
